Company intelligence / Profile preview

WuXi AppTec

Shanghai, Shanghai, Chinaadvancedtherapies.com ↗

Ownership: Private
Employees: ~30000
Development stage: Commercial

Overview

As a leading global CRO/CDMO, WuXi AppTec enables pharmaceutical and biotech companies to accelerate drug discovery and development. The company itself does not report clinical results but supports thousands of client programs worldwide with integrated R&D solutions spanning small molecules to advanced biologics.

Modalities: Small moleculesBiologicsCell therapiesGene therapies
Industry: Contract Research Organization

Partnerships

Thousands of global pharma/biotech companies (client relationships)Iovance BiotherapeuticsAstraZeneca’s MedImmune (joint ventures)Thomas Jefferson University Institute for Bioprocessing (academic)

Beyond the preview

Go deeper on WuXi AppTec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on WuXi AppTec.

Explore the full profile